Home/Filings/4/0001213900-21-007713
4//SEC Filing

FS Development Holdings, LLC 4

Accession 0001213900-21-007713

CIK 0001816736other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 3:04 PM ET

Size

17.6 KB

Accession

0001213900-21-007713

Insider Transaction Report

Form 4
Period: 2021-02-05
Transactions
  • Award

    Common Stock

    2021-02-05$10.00/sh+1,500,000$15,000,0001,500,000 total
  • Conversion

    Common Stock

    2021-02-052,928,7500 total
    Exercise: $0.00Common Stock (2,928,750 underlying)
  • Conversion

    Common Stock

    2021-02-05+2,928,7502,928,750 total
Holdings
  • Common Stock

    441,500
Transactions
  • Award

    Common Stock

    2021-02-05$10.00/sh+1,500,000$15,000,0001,500,000 total
  • Conversion

    Common Stock

    2021-02-052,928,7500 total
    Exercise: $0.00Common Stock (2,928,750 underlying)
  • Conversion

    Common Stock

    2021-02-05+2,928,7502,928,750 total
Holdings
  • Common Stock

    441,500
Transactions
  • Conversion

    Common Stock

    2021-02-052,928,7500 total
    Exercise: $0.00Common Stock (2,928,750 underlying)
  • Award

    Common Stock

    2021-02-05$10.00/sh+1,500,000$15,000,0001,500,000 total
  • Conversion

    Common Stock

    2021-02-05+2,928,7502,928,750 total
Holdings
  • Common Stock

    441,500
Transactions
  • Award

    Common Stock

    2021-02-05$10.00/sh+1,500,000$15,000,0001,500,000 total
  • Conversion

    Common Stock

    2021-02-05+2,928,7502,928,750 total
  • Conversion

    Common Stock

    2021-02-052,928,7500 total
    Exercise: $0.00Common Stock (2,928,750 underlying)
Holdings
  • Common Stock

    441,500
Transactions
  • Conversion

    Common Stock

    2021-02-052,928,7500 total
    Exercise: $0.00Common Stock (2,928,750 underlying)
  • Award

    Common Stock

    2021-02-05$10.00/sh+1,500,000$15,000,0001,500,000 total
  • Conversion

    Common Stock

    2021-02-05+2,928,7502,928,750 total
Holdings
  • Common Stock

    441,500
Footnotes (3)
  • [F1]Shares of common stock obtained in private placement of public securities ("PIPE") on February 5, 2021.
  • [F2]These shares of the Issuer's common stock are held of record by FS Development Holdings, LLC ("FSD Holdings"). Foresite Capital Management V LLC ("FCMVLLC") and Foresite Capital Opportunity Management V, LLC ("FCOMVLLC") are general partners, respectively, of Foresite Capital Fund V, L.P. ("Capital Fund V L.P.") and Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V .L.P."), the sole shareholders of FSD Holdings. Each of FCMVLLC, FCOMVLLC, Capital Fund V L.P and Opportunity Fund V L.P. disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.
  • [F3]In connection with the closing of Gemini Therapeutics, Inc.'s (formerly known as FS Development Corp.) business combination, shares of Class B Common Stock of FS Development Corp. converted into common stock of the Issuer .

Documents

1 file

Issuer

Gemini Therapeutics, Inc. /DE

CIK 0001816736

Entity typeother

Related Parties

1
  • filerCIK 0001820810

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 3:04 PM ET
Size
17.6 KB